about
Considering renal risk while managing cancer.The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.Trefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous Metaplasia.Pharmacokinetic and pharmacodynamic considerations of antimicrobial drug therapy in cancer patients with kidney dysfunctionAssociation of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart StudyThe Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees.Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies.Cause-Specific Deaths in Non-Dialysis-Dependent CKDRisk of cancer in retransplants compared to primary kidney transplants in the United StatesFactors Associated with Recovery of Renal Function following Radical Nephrectomy for Kidney NeoplasmsSmoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN).Management of Indeterminate Cystic Kidney Lesions: Review of Contrast-enhanced Ultrasound as a Diagnostic Tool.A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2 ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.The role of cGMP and its signaling pathways in kidney disease.Renal cell carcinoma: new insights and challenges for a clinician scientist.De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997-2012.Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease.Urine and serum midkine levels in an Australian chronic kidney disease clinic population: an observational study.Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?CKD and risk of renal cell carcinoma: a causal association?Not All Deaths in CKD Are from a Broken Heart.Cancer risk associated with chronic diseases and disease markers: prospective cohort study.Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.Prognostic significance of PD-L1 expression on tumor cells and tumor-infiltrating mononuclear cells in upper tract urothelial carcinoma.Preoperative Chronic Kidney Disease Status is an Independent Prognostic Factor in Patients with Renal Cell Carcinoma.Smoking, depression, and hospital costs of respiratory cancers: Examining race and sex variation.
P2860
Q30234338-13972702-8602-4306-949F-2DA3E75F159EQ30277177-193DDE42-6875-478D-B230-6F1CE4A32BBCQ35666227-D5993BC3-048B-4A85-B0F9-CA88922C0568Q35819409-943889A3-4961-4AE8-95A2-1B5A10141234Q35993577-4433FE12-D03E-4363-A4CC-345BFDC038F6Q36003176-AE2B4CA5-A8E5-4B75-B2CC-B9F474136B89Q36078969-9AF82F63-7D4E-4E46-B523-C9D988E937A8Q36104882-B1712708-BD2D-4E67-9204-6DC299FFFE16Q36132792-9F4C956E-CDE8-40AC-B6DF-9AC7B4877F92Q36432888-09D79C81-0A54-4DFB-B7D2-F13FD4D1428DQ37201197-A731C934-B909-41FC-B2BB-0A2CE3976A52Q38367232-A20FAFC3-AF86-44FA-8661-F814CDE8B6CFQ38611700-6A05B899-719B-4AFE-A9B4-3A7C3C7A2F53Q38638652-C4975E62-E6CA-4719-A8C3-2920219F2F9FQ38808544-B03E3EDA-E588-4226-BBB6-DF06874E78A1Q38896087-F68CF176-04E5-45BE-B353-6886ED89FAB4Q39222755-DC8CD780-3EF8-47B2-93A5-8FAF6BD0ACE8Q40286098-5CA03862-A670-4456-87B0-0D61C1E8C2D8Q41337070-125DF18A-0772-4C8A-A84A-AAE8F65CF297Q42368625-30AF1320-2089-4872-A398-D6D6DF7C7F36Q42371674-57EB7B87-3F01-48A8-AFC7-90FE5DE7BAC5Q42920082-C36DA3D7-6E72-4ACB-B3C9-CE3A92FC615DQ43236768-597CC0DB-5BA4-492A-897D-1638D6A36942Q47640913-0C8CB427-D6C3-4D21-8C55-0801BE890A21Q50522825-A1700E47-87E9-42F5-B03F-8CBB3CB96355Q51058859-DC7B3825-B475-45D0-A5C2-5173CA7FACA9Q53169957-EBDA1DFE-E7BF-478A-90D0-A2AD43E26D61Q55155677-2CF06704-30AB-47F4-9F95-5A911E687730
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CKD and the risk of incident cancer.
@ast
CKD and the risk of incident cancer.
@en
CKD and the risk of incident cancer.
@nl
type
label
CKD and the risk of incident cancer.
@ast
CKD and the risk of incident cancer.
@en
CKD and the risk of incident cancer.
@nl
prefLabel
CKD and the risk of incident cancer.
@ast
CKD and the risk of incident cancer.
@en
CKD and the risk of incident cancer.
@nl
P2093
P2860
P356
P1476
CKD and the risk of incident cancer.
@en
P2093
Juan Ordoñez
Natalia Udaltsova
Paul Russo
William T Lowrance
P2860
P304
P356
10.1681/ASN.2013060604
P577
2014-05-29T00:00:00Z